Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repros Therapeutics Inc (NASDAQ:RPRX)

0.2712
Delayed Data
As of 4:00pm ET
 -0.0049 / -1.77%
Today’s Change
0.26
Today|||52-Week Range
2.47
-79.45%
Year-to-Date
No recent news for Repros Therapeutics Inc.

Today’s Trading

Previous close0.28
Today’s open0.27
Day’s range0.26 - 0.28
Volume288,846
Average volume (3 months)635,039
Market cap$10.4M
Dividend yield--
Data as of 4:00pm ET, 08/22/2017

Growth & Valuation

Earnings growth (last year)+41.67%
Earnings growth (this year)-52.86%
Earnings growth (next 5 years)+27.95%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
ARGSArgos Therapeutics I...+0.01+5.64%
HEBHemispherx Biopharma...-0.01-1.59%
ITUSITUS Corp+0.03+5.54%
EPIXESSA Pharma Inc+0.00+1.21%
Data as of 6:29pm ET, 08/22/2017

Financials

Last reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$17.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Larry M. Dillaha
CFO, Secretary &
Principal Accounting Officer
Katherine A. Anderson
Corporate headquarters
Woodlands, Texas

Forecasts